Global In-Vitro Fertilization(IVF) Market by Products; by Procedure Type; by Donor Type; by End Users; and by Region (North America, Europe, Asia Pacific, Latin America, MEA); - Global Forecasts 2021 to 2027

The Global In-Vitro Fertilization Market was valued at USD 14.9 Bn in 2020 and is estimated to reach USD 26.2 Bn by 2027, growing at a CAGR of 8.6% during the forecast period.

In-Vitro Fertilization Market Definition

The In-Vitro Fertilization (IVF) is most effective reproductive technology. During this procedure, the mature eggs are retrieved or collected form the mother and fertilized by the sperms in-vitro. This procedure involves continuous stimulating and monitoring person’s ovulatory process until the stage of formation of embryo. This embryo can be later stored or transferred to women uterus.

In-Vitro Fertilization Market

In-Vitro Fertilization Market Dynamics

Due to rising cases of infertility among the male and female population, there is an increase in rate of in-vitro fertilization. However, this is considerably a major factor propelling the in-vitro fertilization market. Increasing adoption of unhealthy lifestyle such as consumption of fast-food, alcohol, smoking habits due to which the cases of infertility among the population rises. Increasing adoption of in-vitro fertilization among the obese population due to rising miscarriage rate, reduction in pregnancy rate that decrease the live birth rate among over-weighted people is the driving factor influencing the growth of the global in-vitro fertilization industry. For instance, as per the survey conducted by the New Medical Life-Sciences, in April 2021, across the globe, among 4 women, at-least 1 women is suffering from obesity disorder that reduces the rate of successful pregnancy in natural conceptional cycle. Due to these fueling factors, the adoption of in-vitro fertilization techniques increases the growth of global in-vitro fertilization industry.

The Global In-Vitro Fertilization Market Segmentation:

By Products

Instruments

  • Sperm Analyzer Systems
  • Ovum Aspiration Pumps
  • Micromanipulator Systems
  • Incubators
  • Cryo-Systems
  • Sperm Separation Devices
  • IVF Cabinets
  • Anti-vibration Tables
  • Other Instruments

Reagents & Media

  • Cryopreservation Media
  • Ovum Processing Media
  • Embryo Culture Media
  • Sperm Processing Media
  • Chemicals

Disposable/Accessories

By Procedure Type

  • Conventional In-Vitro Fertilization
  • In-Vitro Fertilization with ICSI 

By Donor Type

  • Fresh Non-Donor
  • Fresh Donor
  • Frozen Non-Donor
  • Frozen Donor

By End- Users

  • Hospitals Labs
  • Research Labs
  • Fertility & Surgical Centers
  • Cryo-Banks

By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Company Profiles and Competitive Intelligence

The key players operating in the in-vitro fertilization market are:

  • Thermo Fisher Scientific, Inc.
  • Esco Micro Pte. Ltd.
  • The Cooper Companies Inc.
  • Cook Group
  • Merck KGaA
  • Vitrolife
  • Genea Limited
  • IVFtech ApS
  • FUJIFILM Irvine Scientific
  • The Baker Company, Inc.
  • Kitazato Corporation
  • Rocket Medical plc.
  • Hamilton Thorne Ltd.
  • ZEISS Group
  • FERTIPRO NV
  • Gynotec B.V.
  • Hamilton Thorne Ltd.
  • Auxogyn, Inc.
  • OvaScience, Inc.
  • Boston IVF

Based on products, instruments segment holds the largest market share over the forecast period due to introduction of advance technology in instruments that are used for in-vitro fertilization

Based on the products, the global in-vitro fertilization (IVF) industry has been segmented into instruments, reagents & media, and disposable/ accessories. Further the instruments segment is sub-segmented into sperm analyzer systems, ovum aspiration pumps, micromanipulator systems, incubators, cryo-systems, sperm separation devices, IVF cabinets, anti-vibration tables, and other instruments. The instruments segment is expected to hold the highest market share during the forecast period. This is due to increasing adoption of in-vitro fertilization procedures among the population which is the propelling factor for growth of this segment. The advancement in IVF instruments manufacturing by the major key-players that boosts the in-vitro fertilization industry.

However, the reagent & media segment is estimated to project the fastest growing segment over the forecast period. Further, the reagent & media segment is bifurcated into cryopreservation media, ovum processing media, embryo culture media, sperm processing media, and chemicals. Increasing funding by the key-players for the research activity for enhancement of the culture media is the fuelling factor for fastest growth of the reagent & media segment over the forecast period.

Based on procedure type, in-vitro fertilization with ICSI segment holds the highest share of the in-vitro fertilization market during the forecast period due to more successful rate of fertilization by (Intracytoplasmic Sperm Injection) ICSI procedure

Based on procedure type, the global in-vitro fertilization market is divided into conventional in-vitro fertilization and in-vitro fertilization with ICSI. The in-vitro fertilization with (Intracytoplasmic Sperm Injection) ICSI segment holds the largest share of the in-vitro fertilization industry over the forecast period owing to increasing utilization of ICSI procedure by the maximum number of patients. The fertilization rate improves by ICSI procedure and risk of abnormality in baby is very low which are boosting factors for growth of ICSI procedure type.

Based on end users, fertility & surgical centers segment holds the highest share of the in-vitro fertilization market during the forecast period due to international healthcare professionals are establishing fertility centers

Based on end-users, the in-vitro fertilization market is divided into hospitals labs, research labs, fertility & surgical centers, and cryo-banks. The fertility & surgical centers segment is projected to hold the largest share of the in-vitro fertilization industry over the forecast period. This is due to increasing popularity of ICSI procedures and in-vitro fertilization globally are the factors that are responsible for the rapid growth of this segment during the forecast period. Increasing preference towards the fertility & surgical centers in order to avoid the hospital acquired infections during the in-vitro fertilization procedure is the fuelling factor for the growth of fertility & surgical centers segment.

Based on region, Asia Pacific estimated to grow at the fastest rate during the forecast period

Asia pacific is expected to grow at the fastest rate over the forecast period. This is due to increasing medical tourism in Asia- pacific and rising awareness related to the in-vitro fertilization techniques are the fuelling factor for the growth of in-vitro fertilization industry in this region. Increasing demand for in-vitro fertilization due to rising fertility clinics and expenditure costs in this region drives the in-vitro fertilization industry growth.

The report also provides an in-depth analysis of the global in-vitro fertilization market dynamics such as drivers, restraints, opportunities, and challenges

Drivers

  • Increasing adoption of in-vitro fertilization by the median age of first-time mothers
  • Increasing male & female infertility cases due to adoption of unhealthy lifestyle
  • Improving in-vitro fertilization technology such as genetic testing methods to achieve higher accuracy

Restraints

  • High cost of in-vitro fertilization due to high cost of products
  • Strict government regulation due to ethical concerns

Opportunities

  • Increasing awareness about availability of treatment for infertility   
  • Rising the rate of medical tourism in emerging regions

Challenges

  •  Reduction in success rate of in-vitro fertilization treatment among the population with advancing ages       

COVID-19 Impact on the Global In-Vitro Fertilization Market

During COVID- 19, the demand for in-vitro fertilization procedures declines due to most of the hospitals turned into COVID-19 centers to treat COVID patients. Moreover, during the lockdown IVF centers terminate the IVF procedures to control the spread of COVID-19. All over the world, the repro-tourism for fertilization procedures reduces significantly due to restriction on travelling during this pandemic. In October 2020, according to a survey conducted by the American Society of Reproductive Medicines, about 62% of population among the survey could have undergone IVF treatment after the fertility centers resume. Therefore, outbreak of COVID-19 has hampered the growth of in-vitro fertilization industry.

The report also provides an in-depth analysis of key trends in global in-vitro fertilization market

Sr. No. Trends Impact
1 Increasing trend towards donating the embryo by the young population for the research and development of advanced in-vitro fertilization techniques  Positive
2 Rising awareness about preservation of oocytes by most of the women in their 20’s or 30’s due to the probability of postponing pregnancy until they feel comfortable Positive

The report also provides an in-depth analysis of recent news developments and investments

  • In January 2021, Merck KGaA (Germany) and Royal Philips (Amsterdam, Netherland) collaborated to develop digital solutions for customized reproductive treatments. These solutions made to advise patients and physicians on the choice and timing of fertility treatment. This collaboration increases their product portfolio and these technological advancements help to people suffering from infertility.
  • In January 2020, Merck KGaA (Germany) received European Commission (EC) Marketing Authorization (MA) for its novel GONAL-f (follitropin alfa) 150 IU pen, which is intended for patients from the start to end of their reproductive stimulation cycle and requires lesser doses which help the patient during pregnancy.

The unique insights provided by this report also includes the following:

  • In-Depth Value Chain Analysis
  • Opportunity Mapping
  • Sector Snapshot
  • Key Players Positioning Matrix
  • Regulatory Scenario
  • Strategies Adopted-Benchmarking Heat Map
  • Market Trends
  • COVID-19 Impact Analysis
  • Product Comparison
  • Pre & Post COVID 19 Impact on The Global In-Vitro Fertilization Market 
  • Competitive Landscape

Frequently Asked Questions (FAQs)

The global market is estimated to be USD 14.9 Bn in 2020 and is expected to reach USD 26.2 Bn by 2027

The global in-vitro fertilization market is estimated to grow at a compound annual growth rate (CAGR) of 8.6% during the forecast period

High cost of IVF hampers the growth of the global market.

Increasing prevalence of infertility is the major driving factor for the growth of the global in-vitro fertilization market.

The 2020 is the base year provided in the report of global market.

Related Reports

Need specific market information ?

Ask for free product review call with the author

Share your specific research requirements for a customized report

Request for due diligence and consumer centric studies

Request for study updates, segment specific and country level reports

  1. Introduction
    1. Product Outline
    2. What is In-Vitro Fertilization?
    3. Different Types in In-Vitro Fertilization
    4. Supply Chain Analysis
    5. COVID -19 Impact
    6. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunities
      4. Threats
  2. Regulatory Landscape for Global In-Vitro Fertilization Market 
    1. Regulations and Standards
  3. Global In-Vitro Fertilization Market by Products
    1. Instruments
      1. Sperm Analyzer Systems
      2. Ovum Aspiration Pumps
      3. Micromanipulator Systems
      4. Incubators
      5. Cryo-Systems
      6. Sperm Separation Devices
      7. IVF Cabinets
      8. Anti-vibration Tables
      9. Other Instruments
    2. Reagents & Media
      1. Cryopreservation Media
      2. Ovum Processing Media
      3. Embryo Culture Media
      4. Sperm Processing Media
      5. Chemicals
    3. Disposable/ Accessories
  4. Global In-Vitro Fertilization Market by Procedure Type
    1. Conventional In-Vitro Fertilization
    2. In-Vitro Fertilization with ICSI  
  5. Global In-Vitro Fertilization Market by Donor Type
    1. Fresh Non-Donor
    2. Fresh Donor
    3. Frozen Non-Donor
    4. Frozen Donor
  6. Global In-Vitro Fertilization Market by End Users
    1. Hospitals Labs
    2. Research Labs
    3. Fertility & Surgical Centers
    4. Cryo-Banks
  7. Regional Analysis
    1. North America
      1. US
      2. Canada
    2. Europe
      1. Germany
      2. UK
      3. France
      4. Italy
      5. Spain
      6. Rest Of Europe
    3. Asia Pacific
      1. China
      2. India
      3. Japan
      4. Rest Of Asia Pacific
    4. Middle East and Africa (MEA)
      1. GCC
      2. Rest of MEA
    5. South America
      1. Brazil
      2. Mexico
      3. Rest of South America   
  8. Key Strategic Insights
    1. New Development
    2. Opportunity Mapping
    3. Critical Success Factors
    4. Competitive Strategies of Key Players
      1. Mergers and Acquisitions
      2. Investments
      3. Joint Ventures
  9. Key Market Trends / Recent Developments
  10. Key Global Players
    1. Thermo Fisher Scientific, Inc.
    2. Esco Micro Pte. Ltd.
    3. The Cooper Companies Inc.
    4. Cook Group
    5. Merck KGaA
    6. Vitrolife
    7. Genea Limited
    8. IVFtech ApS
    9. FUJIFILM Irvine Scientific
    10. The Baker Company, Inc.
    11. Kitazato Corporation
    12. Rocket Medical plc.
    13. Hamilton Thorne Ltd.
    14. ZEISS Group
    15. FERTIPRO NV

Choose License

License Type
Ask for Customization

Why Choose AllTheResearch?

  • Monthly market updates for 6 months
  • Online access of reports
  • Options to buy sections of report
  • Critically analysed research on Quadrant Positioning of your company.
  • Syndicated report along with a supplementary report with objective-based study
  • Get profiled in the reports.Expanding your visibility across our network of readers and viewers
  • We provide local market data in local language on request
  • A complementary co-branded white paper
  • Flat consulting fee based exclusive studies. Consult at the price of syndicate
  • Access to expert team for free transaction advisory service.
Speak to Analyst

Quick Inquiry

Follow Us

Choose License

License Type
Ask for Customization